Pages that link to "Q48716348"
Jump to navigation
Jump to search
The following pages link to Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy (Q48716348):
Displaying 50 items.
- The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay (Q21284813) (← links)
- Positional therapy for obstructive sleep apnoea (Q24200777) (← links)
- Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats (Q26747585) (← links)
- Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease (Q26748713) (← links)
- Hypoxia: The Force that Drives Chronic Kidney Disease (Q26768865) (← links)
- Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism (Q26999248) (← links)
- Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach (Q28076146) (← links)
- Reactive oxygen species in inflammation and tissue injury (Q28396273) (← links)
- Etiopathogenetic mechanisms of pulmonary hypertension in sleep-related breathing disorders (Q30419870) (← links)
- Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure (Q30434409) (← links)
- Pathophysiology of sleep apnea (Q30440658) (← links)
- Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method (Q30455065) (← links)
- Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report (Q30477320) (← links)
- SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS (Q30494316) (← links)
- Glucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot study (Q33578344) (← links)
- Oxidative stress in children with obstructive sleep apnea syndrome (Q33651657) (← links)
- Time course of intermittent hypoxia-induced impairments in resistance artery structure and function (Q33652144) (← links)
- Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea (Q33748662) (← links)
- Systems biology analyses of gene expression and genome wide association study data in obstructive sleep apnea (Q33759579) (← links)
- Neuronal death during combined intermittent hypoxia/hypercapnia is due to mitochondrial dysfunction (Q33929792) (← links)
- Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea (Q34033423) (← links)
- Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients (Q34122262) (← links)
- Sleep-disordered breathing and cardiovascular disorders (Q34273305) (← links)
- Targeting NOX enzymes in the central nervous system: therapeutic opportunities. (Q34285497) (← links)
- The Impact of Obstructive Sleep Apnea on Chronic Kidney Disease (Q34288892) (← links)
- Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential (Q34289495) (← links)
- Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients (Q34325896) (← links)
- Sleep-disordered breathing, control of breathing, respiratory muscles, pulmonary function testing, nitric oxide, and bronchoscopy in AJRCCM 2000. (Q34435272) (← links)
- Sleep apnea and cardiovascular disease (Q34467343) (← links)
- Use of continuous positive airway pressure for sleep apnea in the treatment of hypertension (Q34487311) (← links)
- Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea (Q34535079) (← links)
- Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea (Q34622369) (← links)
- Lifestyle effects on hematopoiesis and atherosclerosis (Q34668164) (← links)
- Obstructive sleep apnoea/hypopnoea syndrome and hypertension. (Q34783095) (← links)
- Obstructive sleep apnoea and its cardiovascular consequences (Q34909223) (← links)
- Reactive oxygen species and the brain in sleep apnea (Q34939523) (← links)
- Endothelial function in obstructive sleep apnea (Q35086889) (← links)
- Obstructive sleep apnea, inflammation, and the metabolic syndrome (Q35104040) (← links)
- White matter damage and systemic inflammation in obstructive sleep apnea (Q35104910) (← links)
- Cardiovascular consequences of obstructive sleep apnea (Q35151651) (← links)
- Sleep-disordered breathing, glucose intolerance, and insulin resistance (Q35174358) (← links)
- Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils. (Q35219730) (← links)
- Sleep disorder and cardiovascular risk factors among patients with type 2 diabetes mellitus (Q35331587) (← links)
- Mechanisms and clinical consequences of untreated central sleep apnea in heart failure (Q35335969) (← links)
- Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy (Q35533588) (← links)
- Obesity, Sleep Apnea, and Hypertension (Q35580802) (← links)
- Sleep disordered breathing and its treatment in congestive heart failure (Q35584743) (← links)
- Obesity and obstructive sleep apnea (Q35623024) (← links)
- Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals. (Q35625951) (← links)
- Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea (Q35761898) (← links)